feed,title,long_url,short_url
Benzinga,AB Science announces that confirmatory Phase 3 study AB12005 with masitinib in first line pancreatic cancer with pain was successful,https://www.benzinga.com/pressreleases/20/12/g18648437/ab-science-announces-that-confirmatory-phase-3-study-ab12005-with-masitinib-in-first-line-pancreat,https://j.mp/3mFDATH
